Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs

Author(s):  Bramwell Bethany L, Williams LaVonn A

Issue:  Jan/Feb 2012 - Volume 16, Number 1
View All Articles in Issue

Page(s):  62-63

The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Page 1
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Page 2

Download in electronic PDF format for $65

Abstract:  This article provides a brief and basic discussion of Pluronic lecithin organogel to include its history, its components, its mechanism of action, the range of active pharmacological agents that can and cannot be incorporated into a Pluronic lecithin organogel, as well as important information for those pharmacists who compound Pluronic lecithin organogel.

Related Keywords: Bethany L. Bramwell, BS Pharm, RPh, LaVonn A. Williams, Pluronic lecithin organogels, PLO, skin permeability, compatibility, transdermal drug delivery

Related Categories: DERMATOLOGY, EXCIPIENTS, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Bramwell Bethany L
, Williams LaVonn A
Jan/Feb 2012
Pg. 62-63

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James
, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2004
Pg. 101-105

Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS
, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014
Pg. 256-261

The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP
Allen Loyd V Jr
May/Jun 2003
Pg. 180-183

Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel
, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2013
Pg. 247-253

Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Glisson James K
, Wood Rebecca L, Kyle Patrick B, Cleary John D
May/Jun 2005
Pg. 242-246

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
Jul/Aug 2021
Pg. 322

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions